Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 0 | 0 | 36,650 | 23,020 | 23,590 |
| Cost of Goods | N/A | N/A | 17,320 | 6,250 | 2,520 |
| Gross Profit | N/A | 28,990 | 19,330 | 16,770 | 21,070 |
| Operating Expenses | 0 | 36,240 | 60,490 | 55,850 | 62,360 |
| Operating Income | N/A | -36,240 | -40,840 | -38,830 | -40,770 |
| Interest Expense | 0 | 0 | 10 | 30 | 60 |
| Other Income | 0 | 0 | 1,420 | 1,550 | 9,170 |
| Pre-tax Income | 0 | -36,240 | -39,430 | -37,310 | -31,660 |
| Income Tax | N/A | N/A | -1,690 | -2,110 | -4,280 |
| Net Income Continuous | N/A | -12,084 | -37,245 | -35,201 | -27,377 |
| Net Income | $N/A | $-12,084 | $-37,730 | $-35,200 | $-27,370 |
| EPS Basic Total Ops | N/A | -0.50 | -1.55 | -1.48 | -1.19 |
| EPS Basic Continuous Ops | N/A | -0.50 | -1.55 | -1.48 | -1.19 |
| EPS Diluted Total Ops | N/A | -0.50 | -1.55 | -1.48 | -1.19 |
| EPS Diluted Continuous Ops | N/A | -0.50 | -1.55 | -1.48 | -1.19 |
| EBITDA(a) | $N/A | $-29,000 | $-34,650 | $-33,200 | $-36,030 |